Equity Capital Markets

Company · CIK 1840233

Xilio Therapeutics, Inc.

CIK1840233 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressMA
ListedXLO (Nasdaq)
First annual or quarterly report2021-12-02

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-295785
ShelfEffective
 2026-05-122026-05-292
333-285703
ShelfEffective
 2025-03-112026-02-126
333-268264
ShelfEffective
 2022-11-092025-03-114
333-279015
ShelfEffective
 2024-04-302024-05-062
333-259973
IPOFinal prospectus
 2021-10-012021-10-225

Filings

20
FiledFilingRegistrationAccession
2026-05-29EFFECTDeclared effective 333-2957859999999995-26-001811
2026-05-12S-3Shelf registered 333-2957850001193125-26-218212
2026-02-12424B5Shelf takedown 333-2857030001193125-26-048934
2026-02-11424B5Shelf takedown 333-2857030001193125-26-046842
2025-06-03424B5Shelf takedown 333-2857030001193125-25-133768
2025-06-02424B5Shelf takedown 333-2857030001193125-25-132745
2025-05-08EFFECTDeclared effective 333-2857039999999995-25-001467
2025-03-11S-3Shelf registered 333-2857030001193125-25-051570
2025-03-11424B5Shelf takedown 333-2682640001193125-25-051529
2024-05-06EFFECTDeclared effective 333-2790159999999995-24-001398
2024-04-30S-3Shelf registered 333-2790150001558370-24-006287
2024-04-15424B5Shelf takedown 333-2682640001558370-24-005063
2022-11-18EFFECTDeclared effective 333-2682649999999995-22-003353
2022-11-09S-3Shelf registered 333-2682640001104659-22-116485
2021-10-22424B4Final prospectus 333-2599730001104659-21-128952
2021-10-21EFFECTDeclared effective 333-2599739999999995-21-003986
2021-10-20S-1/AAmendment 333-2599730001104659-21-127723
2021-10-18S-1/AAmendment 333-2599730001104659-21-126920
2021-10-01S-1Registration filed 333-2599730001104659-21-122045
2021-05-24DRSDraft made public 377-049230001104659-21-071220

All filings of this company · CSV